Mechanically, we identified reactive oxygen species (ROS) as the critical mediator in NOXA upregulation and p38 MAPK pathway activation in RG7388 treated TP53mutant NSCLC. This evidence concerns the gene PMAIP1 and non-small cell lung carcinoma.